DAFNA Capital Management LLC - BIOPHARMX CORP ownership

BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 21 filers reported holding BIOPHARMX CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of BIOPHARMX CORP
ValueSharesWeighting
Q1 2017$58,000
+100.0%
115,000
+49.3%
0.05%
+96.0%
Q4 2016$29,000
-81.9%
77,031
-47.5%
0.02%
-81.9%
Q1 2016$160,000146,8000.14%
Other shareholders
BIOPHARMX CORP shareholders Q2 2017
NameSharesValueWeighting ↓
Vivo Capital, LLC 14,096,338$6,752,0001.70%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 58,027$28,0000.01%
Virtu KCG Holdings LLC 503,418$241,0000.01%
Baker Brothers Advisors 598,758$287,0000.00%
Moors & Cabot, Inc. 40,000$19,0000.00%
FRANKLIN RESOURCES INC 9,499,615$4,550,0000.00%
TWO SIGMA SECURITIES, LLC 11,385$5,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 323,967$155,0000.00%
GUGGENHEIM CAPITAL LLC 22,718$11,0000.00%
OPPENHEIMER & CO INC 28,000$13,0000.00%
View complete list of BIOPHARMX CORP shareholders